Biotechnology Tools and Techniques: A Laboratory Guide
Biotechnology laboratories use techniques ranging from century-old microbiology methods to tools invented within the past decade. The following methods appear in virtually every biotech setting, regardless of whether the lab develops drugs, improves crops, or produces industrial enzymes.
PCR: Polymerase Chain Reaction
PCR copies a specific DNA sequence exponentially, generating billions of copies from a single starting molecule within hours. Invented by Kary Mullis in 1983 (Nobel Prize 1993), PCR remains the most fundamental and widely used technique in molecular biology.
How it works: The reaction contains template DNA, two short DNA primers (flanking the target sequence), free nucleotides (dNTPs), and a heat-stable DNA polymerase (Taq polymerase, from the thermophilic bacterium Thermus aquaticus). The reaction cycles through three temperatures: 95C (separates double-stranded DNA into single strands), 55-65C (primers bind to complementary sequences), and 72C (polymerase extends primers, copying the target region). Each cycle doubles the number of copies. After 30 cycles, one molecule becomes roughly one billion.
Applications: COVID-19 diagnostic testing (RT-qPCR detecting viral RNA), forensic DNA profiling from crime scenes, genetic disease screening, food safety testing for pathogens, cloning gene preparation, and ancestry/paternity testing. Quantitative PCR (qPCR) measures the amount of starting template by tracking amplification in real time using fluorescent dyes.
Variants: RT-PCR first converts RNA to DNA using reverse transcriptase, enabling detection of RNA viruses and gene expression analysis. Digital PCR partitions the reaction into thousands of microdroplets for absolute quantification without calibration curves. Long-range PCR amplifies fragments up to 40 kilobases for structural variant analysis.
Gel Electrophoresis
Gel electrophoresis separates molecules by size using an electric field. DNA, RNA, and proteins carry electrical charges that cause them to migrate through a porous gel matrix (agarose for DNA/RNA, polyacrylamide for proteins) when voltage is applied. Smaller molecules travel faster through the gel pores.
How it works: The gel (a semisolid slab with wells cast into one end) is submerged in buffer solution. Samples are loaded into wells and voltage applied (typically 80-120V for DNA, 100-200V for protein). After 30-90 minutes, molecules have separated by size. DNA is visualized with fluorescent dyes (ethidium bromide, SYBR Safe) under UV light. Proteins are stained with Coomassie Blue or silver stain.
Applications: Confirming PCR product size, checking restriction enzyme digestion patterns, verifying cloning success, DNA fingerprinting, monitoring protein expression levels, and quality control of purified proteins. Size is determined by comparison to molecular weight markers (ladders) run alongside samples.
Western Blotting: A specialized extension where proteins separated by gel electrophoresis are transferred to a membrane and probed with antibodies specific to the target protein. This detects specific proteins within complex mixtures and confirms their size, making it essential for validating recombinant protein production and studying gene expression.
Molecular Cloning
Molecular cloning inserts a gene of interest into a vector (a DNA carrier molecule, usually a plasmid) that replicates in host cells, producing unlimited copies of the gene and its protein product. This is how most recombinant proteins (insulin, growth hormones, industrial enzymes) are manufactured.
How it works: Restriction enzymes cut both the gene of interest and the vector at specific DNA sequences, creating compatible sticky ends. DNA ligase enzyme joins the gene into the vector, creating a recombinant plasmid. This plasmid is introduced into host cells (E. coli bacteria, yeast, or mammalian cells) through transformation (bacteria), electroporation, or transfection (mammalian cells). Cells containing the plasmid are selected using antibiotic resistance markers encoded on the vector.
Modern approaches: Gibson Assembly joins multiple DNA fragments simultaneously without restriction enzymes, using overlapping sequences and a cocktail of three enzymes. Golden Gate Assembly uses Type IIS restriction enzymes to assemble 10+ fragments in a single reaction. Gateway cloning uses site-specific recombination for rapid shuttling of genes between different expression vectors.
Expression systems: E. coli produces simple proteins quickly and cheaply (grams per liter in 24 hours). Yeast (Pichia pastoris, Saccharomyces cerevisiae) adds glycosylation and handles more complex proteins. CHO cells produce antibodies and other human glycoproteins requiring mammalian post-translational modifications. Insect cells (Sf9, Hi5) using baculovirus vectors produce complex proteins with simpler glycosylation than mammalian cells.
Cell Culture
Cell culture grows living cells outside their original organism under controlled laboratory conditions. This enables drug testing on human cells without human subjects, large-scale protein production, gene therapy vector manufacturing, and tissue engineering.
Bacterial culture: E. coli grows in LB (Lysogeny Broth) medium at 37C with orbital shaking (225 RPM for aeration). Doubling time is 20 minutes under optimal conditions, meaning a single cell becomes 10 billion cells overnight. Antibiotic selection ensures only cells carrying the desired plasmid survive. Inducible promoters (IPTG-inducible lac promoter, arabinose-inducible araBAD) allow protein production to be switched on at the optimal cell density.
Mammalian cell culture: CHO cells, HEK293, and other mammalian lines grow in specialized serum-free media at 37C with 5% CO2 atmosphere. Adherent cells grow on treated plastic surfaces. Suspension cells grow in spinner flasks or bioreactors. Doubling times of 18-24 hours mean reaching production density takes 5-7 days. Contamination (bacteria, mycoplasma, cross-contamination with other cell lines) is a constant threat requiring strict aseptic technique and regular testing.
Scale-up: Research begins in T-flasks (25-175 cm2 surface area) or shake flasks (125 mL to 5 L). Pilot production uses bench-top bioreactors (2-50 L). Manufacturing scale ranges from 200 L (gene therapy vectors) to 25,000 L (monoclonal antibodies). Maintaining identical cell behavior across 1,000-fold scale differences requires careful process development and characterization.
CRISPR Gene Editing
CRISPR-Cas9 makes targeted cuts in DNA at researcher-specified locations, enabling precise gene knockouts, insertions, and corrections. The system requires only two components: a guide RNA (gRNA) programmed to match the target DNA sequence, and the Cas9 nuclease protein that cuts where the gRNA directs it.
How it works: The researcher designs a 20-nucleotide guide RNA sequence complementary to the target genomic site (must be adjacent to a PAM sequence, NGG for standard SpCas9). The gRNA and Cas9 protein form a complex that scans genomic DNA. When the gRNA base-pairs with its target, Cas9 cuts both DNA strands. The cell's natural repair machinery either introduces small insertions/deletions (disrupting the gene, called NHEJ) or incorporates a provided DNA template (precise correction or insertion, called HDR).
Delivery methods: In cell lines, Cas9 and gRNA are introduced via plasmid transfection, viral vectors, or direct ribonucleoprotein (RNP) electroporation. RNP delivery is preferred for therapeutic applications because it leaves no DNA in the cell and Cas9 degrades within hours, minimizing off-target editing. For in vivo editing, lipid nanoparticles or AAV vectors deliver CRISPR components to specific tissues.
Screening and validation: After editing, individual cell clones are isolated and their target sites sequenced. T7 Endonuclease I assays or Sanger sequencing identify clones with successful edits. Whole-genome sequencing checks for off-target cuts at predicted similar sequences. Functional assays confirm the edit produces the desired biological effect.
Protein Purification
Protein purification isolates a target protein from the thousands of other proteins, nucleic acids, lipids, and small molecules present in cell lysate. Biopharmaceutical production requires purity exceeding 99.9%, with specific limits on host cell protein, DNA, endotoxin, and aggregates.
Cell lysis: Cells are broken open using mechanical methods (homogenization, sonication, French press), chemical detergents, or enzymatic digestion (lysozyme for bacteria). The resulting crude lysate contains the target protein mixed with all other cellular contents.
Chromatography techniques: Affinity chromatography captures the target using a specific binding partner immobilized on resin beads. Protein A chromatography captures antibodies through their Fc region (the single most important step in antibody manufacturing). His-tag chromatography captures engineered proteins bearing a polyhistidine tag via nickel or cobalt metal ions. Ion exchange chromatography separates proteins by charge. Size exclusion chromatography separates by molecular weight.
Typical purification train for antibodies: Protein A capture (removes 99% of impurities in one step), low pH viral inactivation (safety requirement for animal cell products), anion exchange chromatography (removes DNA, endotoxin, and viruses), mixed-mode or hydrophobic interaction chromatography (removes aggregates and host cell proteins), viral filtration (20nm filter removes any remaining virus particles), and ultrafiltration/diafiltration (concentrates and formulates the final product).
DNA Sequencing Technologies
Sanger sequencing (first generation, 1977) reads single DNA fragments up to 1,000 bases long with very high accuracy (99.99%). It uses chain-terminating dideoxynucleotides labeled with fluorescent dyes, producing reads through capillary electrophoresis. Still used for confirming plasmid constructs, verifying CRISPR edits, and clinical diagnostic sequencing of individual genes.
Illumina sequencing (second generation, 2006 onward) reads millions of short fragments (150-300 bases) simultaneously through sequencing-by-synthesis on a flow cell surface. A full human genome (30x coverage) costs under $200 and completes in 24 hours. This platform dominates genomics research, clinical whole-genome sequencing, transcriptomics (RNA-Seq), epigenomics, and metagenomics.
Nanopore sequencing (third generation, Oxford Nanopore) reads single DNA molecules as they pass through protein nanopores, producing reads exceeding 100,000 bases. The MinION device is palm-sized and costs $1,000, enabling sequencing anywhere (field stations, hospitals, even the International Space Station). Long reads resolve repetitive genomic regions and structural variants that short-read technology misses.
Flow Cytometry and Cell Sorting
Flow cytometry analyzes individual cells at rates of 10,000-100,000 per second as they pass single-file through a laser beam. Fluorescent antibodies bound to cell surface markers identify cell types, activation states, and protein expression levels. This technique is essential for immune cell characterization, CAR-T therapy manufacturing, and stem cell isolation.
Fluorescence-Activated Cell Sorting (FACS) extends flow cytometry by physically separating cells based on their fluorescence profiles. Cells of interest are deflected into collection tubes by electromagnetic fields applied to charged droplets. This enables isolation of rare cell populations (stem cells, antigen-specific T cells, single clones with desired properties) from complex mixtures.
Biotechnology's power comes from a toolkit that manipulates DNA (PCR, cloning, CRISPR, sequencing), grows cells at scale (culture, fermentation), and purifies products to specification (chromatography, filtration). Mastering these techniques enables everything from a $2 million gene therapy to a $0.50 box of laundry detergent enzymes. The tools are shared across all biotech branches, differing only in how they are combined and scaled.